Glucotrack (GCTK) Amortization of Deferred Charges (2024 - 2025)

Glucotrack (GCTK) posted Amortization of Deferred Charges of $177000.0 for Q4 2025, up 470.97% on a QoQ basis from $31000.0 in Q3 2025, and down 40.6% year-over-year from $298000.0 in Q4 2024.

Glucotrack (GCTK) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Glucotrack's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $177000.0 for Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 40.6% year-over-year to $177000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 66.08% YoY) and the FY2025 annual result came in at $182000.0, down 71.02% from the prior year.
  • Amortization of Deferred Charges was $177000.0 for Q4 2025 at Glucotrack, up from $31000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $298000.0 in Q4 2024 and bottomed at $2000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 125.56 Bn 120.35 Bn 1.96 Bn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn
3 Alcon 33.08 Bn 31.43 Bn 1.53 Bn
4 Medline 32.76 Bn 30.53 Bn 1.84 Bn
5 Resmed 29.25 Bn 27.59 Bn 890.98 Mn
6 West Pharmaceutical Services 23.67 Bn 23.24 Bn 329.20 Mn
7 Solventum 13.99 Bn 13.43 Bn 1.10 Bn
8 Cooper Companies 13.87 Bn 13.73 Bn 735.40 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Glucotrack 181,359.45 -7.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 177,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 31,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 3,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 298,000.00
Dec 31, 2024 298,000.00
Sep 30, 2024 251,000.00
Sep 30, 2024 251,000.00
Mar 31, 2024 79,000.00
Mar 31, 2024 79,000.00